Medivation is based out of San Francisco. Medivation, Inc. (Medivation), together with its operating subsidiaries, is a biopharmaceutical company engaged in the acquisition, research and development of promising medical technologies. The Company's portfolio consists of small molecule drugs in development to treat three medical needs: Dimebon for the treatment of Alzheimer's disease, Dimebon for the treatment of Huntington's disease, and MDV3100 for the treatment of hormone-refractory prostate cancer. The Company has two operating subsidiaries: Medivation Neurology, Inc. (MNI) that holds the Company's Dimebon technology, and Medivation Prostate Therapeutics, Inc. (MPT) that holds the Company's MDV300 series technology.Whalewisdom has at least 1 13G filings, and 247 Form 4 filings The firm has no submitted 13F filings and does not appear to be an investment advisor.
Contact Info
Contact information is taken directly from publicly disclosed SEC filings.
MEDIVATION, INC.201 SPEAR STREET, 3RD FLOOR
SAN FRANCISCO CA 94105
Business Phone: 415-543-3470
SEC SIC CODE:
6770-BLANK CHECKS
6770-BLANK CHECKS